Enlivex Therapeutics Stock Price Prediction
| ENLV Stock | USD 1.30 0.28 17.72% |
Oversold Vs Overbought
57
Oversold | Overbought |
Enlivex Therapeutics stock price prediction is an act of determining the future value of Enlivex Therapeutics shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Enlivex Therapeutics' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Enlivex Therapeutics and does not consider all of the tangible or intangible factors available from Enlivex Therapeutics' fundamental data. We analyze noise-free headlines and recent hype associated with Enlivex Therapeutics, which may create opportunities for some arbitrage if properly timed.
Below are the key fundamental drivers impacting Enlivex Therapeutics' stock price prediction:EPS Estimate Current Year (0.86) | Wall Street Target Price 12 |
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Enlivex Therapeutics based on different types of headlines from major news networks to social media. The Enlivex stock price prediction module provides an analysis of price elasticity to changes in media outlook on Enlivex Therapeutics over a specific investment horizon. Using Enlivex Therapeutics hype-based prediction, you can estimate the value of Enlivex Therapeutics from the perspective of Enlivex Therapeutics response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Enlivex Therapeutics using Enlivex Therapeutics' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Enlivex using crowd psychology based on the activity and movement of Enlivex Therapeutics' stock price.
Enlivex Therapeutics Implied Volatility | 366.61 |
Enlivex Therapeutics' implied volatility exposes the market's sentiment of Enlivex Therapeutics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Enlivex Therapeutics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Enlivex Therapeutics stock will not fluctuate a lot when Enlivex Therapeutics' options are near their expiration.
This module is based on analyzing investor sentiment around taking a position in Enlivex Therapeutics. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Enlivex Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying Enlivex because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Enlivex Therapeutics after-hype prediction price | USD 1.18 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Enlivex |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Enlivex Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Enlivex Therapeutics After-Hype Price Prediction Density Analysis
As far as predicting the price of Enlivex Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Enlivex Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Enlivex Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Enlivex Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Enlivex Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Enlivex Therapeutics' historical news coverage. Enlivex Therapeutics' after-hype downside and upside margins for the prediction period are 0.06 and 10.49, respectively. We have considered Enlivex Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Enlivex Therapeutics is dangerous at this time. Analysis and calculation of next after-hype price of Enlivex Therapeutics is based on 3 months time horizon.
Enlivex Therapeutics Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Enlivex Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Enlivex Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Enlivex Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.68 | 9.31 | 0.12 | 0.10 | 6 Events / Month | 5 Events / Month | In about 6 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
1.30 | 1.18 | 9.23 |
|
Enlivex Therapeutics Hype Timeline
Enlivex Therapeutics is currently traded for 1.30. The entity has historical hype elasticity of -0.12, and average elasticity to hype of competition of 0.1. Enlivex is expected to decline in value after the next headline, with the price expected to drop to 1.18. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -9.23%, whereas the daily expected return is currently at -0.68%. The volatility of related hype on Enlivex Therapeutics is about 6582.83%, with the expected price after the next announcement by competition of 1.40. The company has price-to-book (P/B) ratio of 0.76. Some equities with similar Price to Book (P/B) outperform the market in the long run. Enlivex Therapeutics recorded a loss per share of 1.47. The entity last dividend was issued on the 6th of March 2019. The firm had 1:8 split on the 6th of March 2019. Given the investment horizon of 90 days the next expected press release will be in about 6 days. Check out Enlivex Therapeutics Basic Forecasting Models to cross-verify your projections.Enlivex Therapeutics Related Hype Analysis
Having access to credible news sources related to Enlivex Therapeutics' direct competition is more important than ever and may enhance your ability to predict Enlivex Therapeutics' future price movements. Getting to know how Enlivex Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Enlivex Therapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| HUT | Hut 8 Corp | (0.19) | 5 per month | 0.00 | (0.05) | 13.12 | (10.72) | 33.24 | |
| HIVE | HIVE Blockchain Technologies | (0.05) | 10 per month | 0.00 | (0.10) | 8.45 | (7.85) | 28.64 | |
| WULF | Terawulf | 0.15 | 12 per month | 6.21 | 0.03 | 12.33 | (11.17) | 43.07 | |
| BITF | Bitfarms | 0.25 | 11 per month | 0.00 | (0.1) | 12.56 | (10.24) | 29.94 | |
| RIOT | Riot Blockchain | (0.58) | 9 per month | 0.00 | (0.11) | 11.81 | (9.12) | 26.75 | |
| CIFR | Cipher Mining | 0.33 | 10 per month | 6.80 | 0.03 | 15.54 | (10.57) | 39.46 | |
| IREN | Iris Energy | 1.08 | 10 per month | 0.00 | (0.02) | 19.81 | (10.64) | 36.90 |
Enlivex Therapeutics Additional Predictive Modules
Most predictive techniques to examine Enlivex price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Enlivex using various technical indicators. When you analyze Enlivex charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Enlivex Therapeutics Predictive Indicators
The successful prediction of Enlivex Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Enlivex Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Enlivex Therapeutics based on analysis of Enlivex Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Enlivex Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Enlivex Therapeutics's related companies. | 2023 | 2024 (projected) | Days Sales Outstanding | 167.93 | 149.27 | PTB Ratio | 1.67 | 1.58 |
Story Coverage note for Enlivex Therapeutics
The number of cover stories for Enlivex Therapeutics depends on current market conditions and Enlivex Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Enlivex Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Enlivex Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
View All Premium Stories
Enlivex Therapeutics Short Properties
Enlivex Therapeutics' future price predictability will typically decrease when Enlivex Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Enlivex Therapeutics often depends not only on the future outlook of the potential Enlivex Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Enlivex Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 18.6 M | |
| Cash And Short Term Investments | 27.4 M |
Check out Enlivex Therapeutics Basic Forecasting Models to cross-verify your projections. For more information on how to buy Enlivex Stock please use our How to Invest in Enlivex Therapeutics guide.You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Complementary Tools for Enlivex Stock analysis
When running Enlivex Therapeutics' price analysis, check to measure Enlivex Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Enlivex Therapeutics is operating at the current time. Most of Enlivex Therapeutics' value examination focuses on studying past and present price action to predict the probability of Enlivex Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Enlivex Therapeutics' price. Additionally, you may evaluate how the addition of Enlivex Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |
Is Enlivex Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Enlivex Therapeutics. If investors know Enlivex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Enlivex Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.47) | Return On Assets (0.30) | Return On Equity (0.67) |
The market value of Enlivex Therapeutics is measured differently than its book value, which is the value of Enlivex that is recorded on the company's balance sheet. Investors also form their own opinion of Enlivex Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Enlivex Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Enlivex Therapeutics' market value can be influenced by many factors that don't directly affect Enlivex Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Enlivex Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Enlivex Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Enlivex Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.